Canada releases final amendments to patented medicines pricing regulations

9 September 2019 - On 9 August 2019 Health Canada announced the final amendments to the Patented Medicines Regulations. ...

Read more →

Pelosi drug pricing plan would let government negotiate most costly medicines

9 September 2019 - The government would be allowed to directly negotiate the prices for some of the most expensive ...

Read more →

Novo Nordisk launching additional US insulin affordability offerings in January 2020

6 September 2019 - $99 Cash Card Program provides 3,000 - 3,600 units of any combination of Novo Nordisk analog insulins ...

Read more →

Trudeau’s drug price overhaul is set to cost drug makers billions

6 September 2019 - Canada revamps drug-pricing regime for first time since 1987. ...

Read more →

It’s time for Congress to go all in on drug pricing reform

6 September 2019 - The partisan stars are appear to be aligned in Washington on passing federal drug pricing reform, ...

Read more →

What is the value of market-wide health care price transparency?

5 September 2019 - A primary driver of high spending in the US health care system, relative to other countries, ...

Read more →

A bipartisan effort: States pass record number of laws to reel in drug prices

5 September 2019 - Whether Congress will act this year to address the affordability of prescription drugs – a high ...

Read more →

Medicare drug price negotiation — why now . . . and how

4 September 2019 - A targeted bargaining strategy using tried and tested arbitration techniques could help Medicare balance drug innovation and ...

Read more →

Proposals to redesign Medicare Part D — easing the burden of rising drug prices

4 September 2019 - Amid concerns about high drug prices, policy makers are considering options for modifying the Medicare Part D ...

Read more →

Capital Rx to inject transparency in prescription drug prices

4 September 2019 - In recent years, the pharmacy benefits management industry's pricing practices have been under intense scrutiny by ...

Read more →

Price rises above inflation already standard for drugs

3 September 2019 - In the past three years, more than half of all sales growth for the top 45-selling drugs ...

Read more →

As Congress considers lowering drug costs, pharma CEOs target key senators with campaign cash

3 September 2019 - Top pharmaceutical CEOs have targeted a small group of Republican senators with roughly $200,000 in campaign ...

Read more →

AARP fights high drug prices on behalf of members

 2 September 2019 - AARP is fighting for change: So far this year, there are 35 new laws across 23 states ...

Read more →

How a powerful lobby group is pushing up PBS medicine prices

30 August 2019 - Aussies are being forced to pay up to six times more for vital medicines despite being listed ...

Read more →

U.S. prices for multiple sclerosis drugs are on the rise

28 August 2019 - Annual costs of disease modifying treatments for multiple sclerosis more than quadrupled from 2006 to 2016 ...

Read more →